CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing new catalytic techniques for the asymmetric synthesis of chiral molecules known as atropisomers, using radical chemistry and visible light photochemistry. The goal is to enhance drug discovery by creating diverse libraries of these compounds for biological screening.
Chiral molecules containing axes of chirality (known as atropisomers) are present in natural products, bioactive molecules, and functional materials.
Their increasingly important role in pharmaceuticals means that effective asymmetric strategies are needed for their preparation.
However, the available catalytic methods rely on ionic pathways, which limits the diversity of atropisomers that can be achieved.
This project seeks to close this gap in asymmetric methodology by providing new catalytic…
ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Leverkusen
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
